Global Diagnostics PCR Market Size By Type (Digital PCR, Multiple PCR), By Application (Infection Disease Diagnosis, Cancer), By Region, And Segment Forecasts, 2023 to 2032

The Global Diagnostics PCR Market was valued at USD 7.4 billion in 2023 and is projected to reach USD 13.6 billion by 2031, expanding at a CAGR of 7.9% during the forecast period from 2023 to 2031. The rising prevalence of infectious diseases, chronic conditions, and cancer, along with the increasing need for accurate and rapid diagnostic techniques, is fueling the demand for polymerase chain reaction (PCR) diagnostics globally.

PCR diagnostics offer high sensitivity and specificity, making them critical in disease detection, genetic analysis, and clinical diagnostics. The post-pandemic healthcare environment has further solidified the importance of PCR-based testing in hospitals, diagnostic laboratories, and point-of-care settings.

Drivers:

Rising Global Burden of Infectious Diseases

Increased outbreaks of infectious diseases such as influenza, tuberculosis, HIV, and emerging zoonotic infections continue to drive demand for accurate diagnostics. PCR’s ability to detect low levels of pathogens with high precision makes it the gold standard in clinical microbiology.

Advancements in PCR Technology

Technological innovations including digital PCR (dPCR), multiplex PCR, and real-time qPCR are improving detection capabilities and workflow efficiency. Integration with microfluidics and AI-based data analysis is making PCR more robust, faster, and easier to use.

Growing Adoption in Oncology and Genetic Testing

The expansion of personalized medicine has led to increased utilization of PCR for detecting genetic mutations and biomarkers associated with cancers and hereditary diseases. PCR is widely used in liquid biopsies and pharmacogenomics, enhancing treatment decision-making.

Restraints:

High Cost of Advanced PCR Systems

Despite the technology’s efficiency, the cost of acquiring and maintaining advanced PCR equipment and reagents remains high, especially for healthcare systems in low- and middle-income countries.

Stringent Regulatory Requirements

Approval and validation of PCR diagnostics by regulatory agencies can be a time-consuming and costly process, which may hinder the entry of new players or delay the launch of innovative products.

Opportunity:

Expansion of Decentralized Testing and Point-of-Care Platforms

The shift toward decentralized healthcare and home-based diagnostics opens new avenues for portable and easy-to-use PCR devices. Growth in demand for rapid, accurate results in non-laboratory settings is expected to propel the market further.

Emerging Markets with Improving Healthcare Infrastructure

Countries in Asia-Pacific, Latin America, and Africa are investing in diagnostics and public health infrastructure. This creates lucrative opportunities for PCR diagnostic manufacturers to expand their presence and meet rising diagnostic demands.

Market by System Type Insights:

Among system types, Real-Time PCR (qPCR) dominated the market in 2023 due to its wide adoption in clinical and research laboratories. It offers high-speed detection with quantification capabilities and is extensively used for detecting infectious agents, cancer markers, and gene expression levels.

Meanwhile, Digital PCR (dPCR) is projected to witness the fastest growth during the forecast period due to its ultra-sensitive capabilities, enabling precise detection of low-level targets, particularly in oncology and virology.

Market by End-use Insights:

In 2023, Hospitals and Diagnostic Laboratories accounted for the largest share of the global diagnostics PCR market. These institutions rely on PCR for a wide range of clinical applications, from pathogen detection to cancer diagnostics.

However, Point-of-Care Testing (POCT) is expected to register the highest growth rate, driven by the demand for rapid diagnostics in remote areas, emergency settings, and for chronic disease monitoring.

Market by Regional Insights:

North America held the dominant position in 2023 due to advanced healthcare infrastructure, widespread adoption of molecular diagnostics, and strong investments in R&D.

Asia-Pacific is anticipated to be the fastest-growing region through 2031, driven by increasing healthcare spending, growing awareness, government-led screening initiatives, and a surge in chronic and infectious diseases.

Competitive Scenario:

Key players in the Global Diagnostics PCR Market include Thermo Fisher Scientific, Roche Diagnostics, Bio-Rad Laboratories, QIAGEN, Abbott Laboratories, Agilent Technologies, Danaher Corporation (Cepheid), Siemens Healthineers, Takara Bio, and Becton Dickinson (BD).

These companies are focusing on technological innovations, strategic collaborations, and geographical expansion. For instance:

In 2023, Roche launched its LightCycler® PRO System, featuring advanced multiplexing and enhanced throughput for clinical diagnostics.

In 2024, Abbott introduced a portable qPCR device tailored for decentralized healthcare settings in emerging markets.

In 2025, Bio-Rad partnered with a leading Asian diagnostics provider to expand its digital PCR footprint across key APAC countries.

Scope of Work – Global Diagnostics PCR Market

Report Metric Details

Market Size (2023) USD 7.4 billion

Projected Market Size (2031) USD 13.6 billion

CAGR (2023-2031) 7.9%

Market Segments System Type (qPCR, dPCR, Others); End-use (Hospitals, Diagnostics Labs, POCT, Research)

Growth Drivers Rising disease burden, oncology and genetics integration, technological advancements

Opportunities Emerging markets, decentralized and point-of-care diagnostics

Key Market Developments:

January 2023: Thermo Fisher expanded its molecular diagnostics portfolio with a new real-time PCR platform optimized for infectious disease panels.

August 2023: QIAGEN received FDA approval for its multiplex PCR assay targeting respiratory pathogens.

March 2024: Siemens Healthineers launched a cloud-enabled PCR diagnostics ecosystem with integrated AI-based analytics for real-time epidemiological surveillance.

FAQs:

1) What is the current market size of the Global Diagnostics PCR Market?

The market was valued at USD 7.4 billion in 2023.

2) What is the major growth driver of the Global Diagnostics PCR Market?

The key driver is the rising global burden of infectious and chronic diseases coupled with advancements in PCR technology.

3) Which is the largest region during the forecast period in the Global Diagnostics PCR Market?

North America currently leads the market, while Asia-Pacific is expected to grow the fastest.

4) Which segment accounted for the largest market share in the Global Diagnostics PCR Market?

The Real-Time PCR (qPCR) segment held the largest market share in 2023.

5) Who are the key market players in the Global Diagnostics PCR Market?

Major players include Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Bio-Rad Laboratories, and Abbott Laboratories.